WallStSmart
IRIX

IRIDEX Corporation

NASDAQ: IRIX · HEALTHCARE · MEDICAL DEVICES

$1.03
+0.00% today

Updated 2026-04-30

Market cap
$18.69M
P/E ratio
P/S ratio
0.36x
EPS (TTM)
$-0.26
Dividend yield
52W range
$1 – $2
Volume
0.3M

IRIDEX Corporation (IRIX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
-1.6%
Last 4 quarters
Revenue YoY growth
+16.0%
Most recent quarter
EPS YoY growth
+78.6%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-12.7%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-13.3%
2025-11-11
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-05$-0.01+46.5%$1.41$1.24-12.1%
2025-11-11$-0.09-54.2%$1.10$0.95-13.3%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.02$-0.01+46.5%$14.72M+16.0%
2025-09-30$-0.06$-0.09-54.2%$12.48M+7.8%
2025-06-30$-0.09$-0.06+33.3%$13.57M+7.4%
2025-03-31$-0.12$-0.10+16.0%$11.90M+1.1%
2024-12-31$-0.05$-0.05-0.2%$12.70M+1.9%
2024-09-30$-0.09$-0.12-33.3%$11.58M-9.9%
2024-06-30$-0.12$-0.16-33.3%$12.63M-1.7%
2024-03-31$-0.12$-0.21-75.0%$11.76M
2023-12-31$-0.05$-0.18-260.0%$12.46M
2023-09-30$-0.12$-0.11+8.3%$12.85M
2023-06-30$-0.11$-0.17-54.5%$12.86M
2023-03-31$-0.12$-0.13-8.3%
2022-12-31$-0.11$-0.07+36.4%

Frequently asked questions

Has IRIDEX Corporation beaten earnings estimates?
IRIDEX Corporation has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports, with an average EPS surprise of -1.6% over the last 3 quarters.
How does IRIX stock react to earnings?
IRIX stock has moved an average of -12.7% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is IRIDEX Corporation's revenue growth rate?
IRIDEX Corporation reported year-over-year revenue growth of +16.0% in its most recent quarter, with EPS growing +78.6% year-over-year.